Journal
AUTOPHAGY
Volume 16, Issue 12, Pages 2123-2127Publisher
TAYLOR & FRANCIS INC
DOI: 10.1080/15548627.2020.1844940
Keywords
ACE2; chloroquine; dexamethasone; hydroxychloroquine; LC3; macroautophagy; remdesivir; TMPRSS2
Categories
Funding
- National Institute of General Medical Sciences [GM131919]
Ask authors/readers for more resources
In the preceding months, the novel SARS-CoV-2 pandemic has devastated global communities. The need for safe and effective prophylactic and therapeutic treatments to combat COVID-19 - the human disease resulting from SARS-CoV-2 infection - is clear. Here, we present recent developments in the effort to combat COVID-19 and consider whether SARS-CoV-2 may potentially interact with the host autophagy pathway.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
